✦ LIBER ✦

Weekly systemic combination of cisplatin and interferon α2a in diffuse malignant pleural mesothelioma

✍ Scribed by Purohit, A.; Moreau, L.; Dietemann, A.; Seibert, R.; Pauli, G.; Wihlm, J.M.; Quoix, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin, ifosfamide and mitomycin comb

✍ Metintas, M; Alatas, F; Harmanci, E; Erginel, S; Metintas, S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Higher doses of α-interferon do not incr

✍ L. Trandafir; P. Ruffié; C. Borel; I. Monnet; P. Soulié; D. Adams; E. Cvitkovic; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 362 KB

Cisplatin, doxorubicin and mitomycin in

✍ Pennucci, M.C.; Ardizzoni, A.; Mariani, G.L.; Giorgi, G.; Rao, F.; Rimoldi, R.; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A phase II study evaluating the cisplati

✍ Berghmans, T.; Lafitte, J.J.; Paesmans, M.; Stach, B.; Berchier, M.C.; Wackenier 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Multicentre phase II study of gemcitabin

✍ van Haarst, J M W; Baas, P; Manegold, C h; Schouwink, J H; Burgers, J A; de Brui 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 78 KB

265 A phase II study of doxorubicin and

✍ Penson, R.T.; Mulatero, C.W.; Gower, N.H.; Evans, M.T.; Rudd, R.M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 305 KB